dipyridamole has been researched along with Skin Neoplasms in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Evidence of systemic toxicity was observed in animals dosed chronically with pyrimethamine or amiloride, but no skin papillomas were observed in mice treated with amiloride, dipyridamole, or pyrimethamine for 26 weeks." | 1.32 | Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components. ( Lin, KK; Rosenzweig, BA; Sistare, FD; Thompson, KL; Weaver, JL; Zhang, J, 2003) |
| "In the presence of a chronic consumption coagulopathy, it remains uncertain whether antiplatelet drugs are of prophylactic antithrombotic value." | 1.28 | Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis. ( Bouquet, J; Hofhuis, WJ; Oranje, AP; Sinaasappel, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, KL | 1 |
| Rosenzweig, BA | 1 |
| Weaver, JL | 1 |
| Zhang, J | 1 |
| Lin, KK | 1 |
| Sistare, FD | 1 |
| Hofhuis, WJ | 1 |
| Oranje, AP | 1 |
| Bouquet, J | 1 |
| Sinaasappel, M | 1 |
| Rhodes, EL | 1 |
| Misch, KJ | 1 |
| Edwards, JM | 1 |
| Jarrett, PE | 1 |
| Gschnait, F | 1 |
| Lechner, K | 1 |
| Riedl, P | 1 |
4 other studies available for dipyridamole and Skin Neoplasms
| Article | Year |
|---|---|
Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
Topics: Acetone; Administration, Topical; Amiloride; Animal Testing Alternatives; Animals; Carcinogenicity T | 2003 |
Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis.
Topics: Anemia, Hemolytic; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Gastrointe | 1990 |
Dipyridamole for treatment of melanoma.
Topics: Dipyridamole; Female; Humans; Male; Melanoma; Skin Neoplasms | 1985 |
[Kasabach-Merritt syndrome].
Topics: Back; Diagnosis, Differential; Dipyridamole; Female; Hemangioma; Heparin; Humans; Penicillins; Purpu | 1973 |